de Vries, Rory D <br/><br/>
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.  [electronic resource] 

 -  The Journal of infectious diseases  07 2018 
 - 614-623 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1537-6613 
<br/><br/><label>Standard No.: </label>10.1093/infdis/jiy214  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Viral--blood<br/>Antibody-Dependent Cell Cytotoxicity<br/>Cross Reactions<br/>Double-Blind Method<br/>Drug Carriers<br/>Female<br/>Hemagglutination Inhibition Tests<br/>Hemagglutinin Glycoproteins, Influenza Virus--genetics<br/>Humans<br/>Immunization Schedule<br/>Influenza A Virus, H5N1 Subtype--genetics<br/>Influenza Vaccines--administration & dosage<br/>Influenza, Human--prevention & control<br/>Male<br/>Neutralization Tests<br/>Protein Array Analysis<br/>T-Lymphocytes--immunology<br/>Vaccines, Synthetic--administration & dosage<br/>Vaccinia virus--genetics<br/>Young Adult